CAS3_METTH
ID CAS3_METTH Reviewed; 830 AA.
AC O27158;
DT 18-APR-2012, integrated into UniProtKB/Swiss-Prot.
DT 01-JAN-1998, sequence version 1.
DT 03-AUG-2022, entry version 125.
DE RecName: Full=CRISPR-associated nuclease/helicase Cas3;
DE EC=3.1.-.-;
DE EC=3.6.4.-;
GN Name=cas3; OrderedLocusNames=MTH_1086;
OS Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM
OS 10044 / NBRC 100330 / Delta H) (Methanobacterium thermoautotrophicum).
OC Archaea; Euryarchaeota; Methanomada group; Methanobacteria;
OC Methanobacteriales; Methanobacteriaceae; Methanothermobacter.
OX NCBI_TaxID=187420;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H;
RX PubMed=9371463; DOI=10.1128/jb.179.22.7135-7155.1997;
RA Smith D.R., Doucette-Stamm L.A., Deloughery C., Lee H.-M., Dubois J.,
RA Aldredge T., Bashirzadeh R., Blakely D., Cook R., Gilbert K., Harrison D.,
RA Hoang L., Keagle P., Lumm W., Pothier B., Qiu D., Spadafora R., Vicare R.,
RA Wang Y., Wierzbowski J., Gibson R., Jiwani N., Caruso A., Bush D.,
RA Safer H., Patwell D., Prabhakar S., McDougall S., Shimer G., Goyal A.,
RA Pietrovski S., Church G.M., Daniels C.J., Mao J.-I., Rice P., Noelling J.,
RA Reeve J.N.;
RT "Complete genome sequence of Methanobacterium thermoautotrophicum deltaH:
RT functional analysis and comparative genomics.";
RL J. Bacteriol. 179:7135-7155(1997).
RN [2]
RP FUNCTION AS A HELICASE, FUNCTION IN FORMING R-LOOPS, AND MUTAGENESIS OF
RP ASP-347.
RC STRAIN=ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H;
RX PubMed=21699496; DOI=10.1042/bj20110901;
RA Howard J.A., Delmas S., Ivancic-Bace I., Bolt E.L.;
RT "Helicase dissociation and annealing of RNA-DNA hybrids by Escherichia coli
RT Cas3 protein.";
RL Biochem. J. 439:85-95(2011).
CC -!- FUNCTION: CRISPR (clustered regularly interspaced short palindromic
CC repeat), is an adaptive immune system that provides protection against
CC mobile genetic elements (viruses, transposable elements and conjugative
CC plasmids). CRISPR clusters contain sequences complementary to
CC antecedent mobile elements and target invading nucleic acids. CRISPR
CC clusters are transcribed and processed into CRISPR RNA (crRNA). Cas3
CC plus Cascade participate in CRISPR interference, the third stage of
CC CRISPR immunity. Anneals and unwinds R-loops (in which crRNA binds the
CC target DNA, displacing the noncomplementary strand). Unwinding requires
CC ATP, annealing does not. {ECO:0000269|PubMed:21699496}.
CC -!- COFACTOR:
CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC -!- DOMAIN: Proteins of this family have an N-terminal nuclease domain and
CC a C-terminal helicase/ATPase domain. In some CRISPR/Cas systems the
CC domains are swapped, in others they are encoded separately.
CC -!- SIMILARITY: In the N-terminal section; belongs to the CRISPR-associated
CC nuclease Cas3-HD family. {ECO:0000305}.
CC -!- SIMILARITY: In the central section; belongs to the CRISPR-associated
CC helicase Cas3 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE000666; AAB85575.1; -; Genomic_DNA.
DR PIR; C69011; C69011.
DR AlphaFoldDB; O27158; -.
DR STRING; 187420.MTH_1086; -.
DR EnsemblBacteria; AAB85575; AAB85575; MTH_1086.
DR KEGG; mth:MTH_1086; -.
DR PATRIC; fig|187420.15.peg.1064; -.
DR HOGENOM; CLU_009347_0_0_2; -.
DR OMA; AIAGPRY; -.
DR Proteomes; UP000005223; Chromosome.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0004518; F:nuclease activity; IEA:UniProtKB-KW.
DR GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR Gene3D; 1.10.3210.30; -; 1.
DR Gene3D; 3.40.50.300; -; 2.
DR InterPro; IPR035011; Cas3.
DR InterPro; IPR006483; CRISPR-assoc_Cas3_HD.
DR InterPro; IPR038257; CRISPR-assoc_Cas3_HD_sf.
DR InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR InterPro; IPR014001; Helicase_ATP-bd.
DR InterPro; IPR006474; Helicase_Cas3_CRISPR-ass_core.
DR InterPro; IPR027417; P-loop_NTPase.
DR PANTHER; PTHR47959:SF5; PTHR47959:SF5; 1.
DR Pfam; PF00270; DEAD; 1.
DR Pfam; PF18019; HD_6; 1.
DR SMART; SM00487; DEXDc; 1.
DR SUPFAM; SSF52540; SSF52540; 1.
DR TIGRFAMs; TIGR01587; cas3_core; 1.
DR TIGRFAMs; TIGR01596; cas3_HD; 1.
DR PROSITE; PS51643; HD_CAS3; 1.
DR PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR PROSITE; PS51194; HELICASE_CTER; 1.
PE 1: Evidence at protein level;
KW Antiviral defense; ATP-binding; Helicase; Hydrolase; Magnesium;
KW Metal-binding; Nuclease; Nucleotide-binding; Reference proteome.
FT CHAIN 1..830
FT /note="CRISPR-associated nuclease/helicase Cas3"
FT /id="PRO_0000416953"
FT DOMAIN 15..250
FT /note="HD Cas3-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00974"
FT DOMAIN 286..471
FT /note="Helicase ATP-binding"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT DOMAIN 503..660
FT /note="Helicase C-terminal"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT BINDING 67
FT /ligand="Mg(2+)"
FT /ligand_id="ChEBI:CHEBI:18420"
FT /evidence="ECO:0000250"
FT BINDING 135
FT /ligand="Mg(2+)"
FT /ligand_id="ChEBI:CHEBI:18420"
FT /evidence="ECO:0000255"
FT BINDING 299..306
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT MUTAGEN 347
FT /note="D->A: Loss of R-loop unwinding."
FT /evidence="ECO:0000269|PubMed:21699496"
SQ SEQUENCE 830 AA; 96329 MW; 6DEE12EA4F047604 CRC64;
MAMMELIDII RAKSNDQRNY LLKDHLKETV ARIDDFHNFY QTNREKFSYK IGEKTFRALA
MASIIHDLGK IDYNFQKKLM GDDSEAWEVL EEFLSPLKPL KRSPRHEILS IIWSTFLLGN
DDLDAMMRTA ILLHHYNEYF LNDKDLMEII FTYRDAFEIY LNFIIEKKET LRIFIEDILN
YIQNSLESDL VISAADEIRS NMDFEKPELL LEKIKEYDDD ISEFAAFYEP EERSADILIL
SGILRRADYS ASAGVDIELF SEEVFRDIDE KITSKIGGAP WQIRLMGELG GPKKMVLVAP
TGSGKTEFSI LWAAKHGRKF IYTLPLRVAL NDIFMRLRDS DGYFSEDEID ILHSTAFIEY
LKEERLGRGT DLDSMMTSAR LMASPALLTT PDQVLITSLN YFGSDKVISV YPFASMILDE
IQTYNEEMAA VIIKTLELVN EVDGNILVMT ATLPPYFRSF LDAMNFEVMD VAAIPGAHDI
KNLNLKRHVP QLIEEPLFND ELEVSDKLGK ILDENSEKNV LIVVNNVQKA IELYREYQDD
PDVYLLHSRL LEKVKSQRIG EVKKRSQDER GLTVISTQII EASVDIDFDL MITEISTIDS
QIQRWGRIHR NRDADYDSGD PNIIIFTDSD RRTSLIYDKK VLDATRAILE RYDGQILDYN
LERSMIEEVF QEEIDGSTLK EIYENQIRET ISDLDYFTVE KRTQAQRLFR NMAGYKVFIP
DAVLRYSESE IERTFAELIK GDYRLWKDIL GEIERITGEK TTMWDLKKVL YEYSVNVPVF
YEEKSDFWSR TTGEFKGFYV WGSMEDDDVE LLEELGLDSI FGETESSLIV